Abstract:O65* Aims: Despite the improved early graft survival, the development of chronic graft rejection mediated by immune and non-immune factors is still the dominant cause of late graft loss. In this study, we investigated the efficacy of gene therapy based on various therapeutic strategies to prevent the development of chronic allograft rejection. Stable expression of transgene (rat indoleamine 2,3-dioxygenase, IDO; human CTLA4Ig; or human IL-10) in the grafts was achieved by using recombinant adeno-associated viral vectors. Methods: Heterotopic heart transplantation was performed using LEW and F344 rats as donors or recipients, respectively. After in situ perfusion of the donor heart with HTK solution, rAAVs (0.5-1×1012 v.g./graft) were infused through the coronary artery. The grafts were then preserved with cold HTK solution for 6 hours before transplantation. The experimental groups were as follows: 1) no treatment; 2) CsA 2.5 mg/kg/d. i.m. d.0-4; 3) rAAV-GFP + CsA; 4) rAAV/IDO + CsA; 5) rAAV/CTLA4Ig + CsA; 6) rAAV/IL-10 + CsA. Results: rAAV/hIL-10 gene transfer could promote long-term graft survival in 5 of 6 animals (MST: >200 days), whereas only 3 of 7 grafts could survive for more than 200 days in the CsA treatment group (MST=21 days, n=6). No IDO-trasnduced grafts could survive for long-term. In addition, no improvement of long-term survival rate of allografts was observed in CTLA4Ig-transduced animals. Although marked reduction of graft infiltrating cells and serum anti-donor antibodies was detected in hCTLA4Ig-transduced animals, massive intimal proliferation of medium arteries and severe narrowing of vessel lumen were found in all hCTLA4Ig-transduced grafts at day 200. Conversely, significant attenuation of obliterative arteriopathy was observed in hIL-10-transduced grafts at day 200 compared with grafts treated with CsA only or vector control. Detection of gene transcript levels of long-term surviving grafts by real-time RT-PCR demonstrated lower TGF-beta1 and higher HO-1 transcript levels in hIL-10-transduced grafts Conclusions: These findings suggest that IL-10 can be an ideal target for therapeutic intervention of chronic allograft rejection.

Mfn2 Inhibits Chronic Rejection of the Rat Abdominal Aorta by Regulating TGF-β1 Levels.

HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs.

Mitofusin-2 Mediated Mitochondrial Ca2+ Uptake 1/2 Induced Liver Injury in Rat Remote Ischemic Perconditioning Liver Transplantation and Alpha Mouse Liver-12 Hypoxia Cell Line Models.

Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

Deletion of Smad3 Improves Cardiac Allograft Rejection in Mice.

Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

Dietary Omega-3 Polyunsaturated Fatty Acids Can Inhibit Expression of Granzyme B, Perforin, and Cation-Independent Mannose 6-Phosphate/insulin-like Growth Factor Receptor in Rat Model of Small Bowel Transplant Chronic Rejection

STABLE EXPRESSION OF INTERLEUKIN-10 SUPPRESSES THE DEVELOPMENT OF CHRONIC ALLOGRAFT REJECTION IN RATS:

Effect of vascular smooth muscle α-actin on cardiac allograft vasculopathy and fibrosis

Overexpression of fibrinogen-like protein 2 alleviates acute rejection in rat models of liver transplantation

Role of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft

Increased Expression of Non-Interleukin-2 T Cell Growth Factors and Their Implications During Liver Allograft Rejection in Rats

Attenuation of Rat Chronic Small Bowel Allograft Rejection by N‐3 Polyunsaturated Fatty Acids is Associated with Reduced Expression of Graft IL‐15

Influence of Renal Transplant Survival in Rats Dendritic Cells(DC2)Conditioned with Donor Kidney Antigen

Transduction of Interleukin-10 Through Renal Artery Attenuates Vascular Neointimal Proliferation and Infiltration of Immune Cells in Rat Renal Allograft.

Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts.

The Inhibitory Effect of TLSF_(JM) on Rat Cardiac Allograft Rejection

Cutting Edge: Membrane Lymphotoxin Regulates Cd8(+) T Cell-Mediated Intestinal Allograft Rejection

Effect of Cyclosporine A Versus Tacrolimus on Chronic Allograft Rejection Following Orthotopic Small Bowel Transplantation in Rats

[Effect of Vascular Smooth Muscle Alpha-Actin on Cardiac Allograft Vasculopathy and Fibrosis].

Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection